POZ October-November 2020
POZ October-November 2020
In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
Features
Your Vote Matters
“The issue is AIDS. Where do the candidates stand on education, health care, discrimination? Your vote is a weapon. Use it. We are at war!”
Speaking With a Collective Voice
In launching a new grassroots network, Latinx people living with HIV define their own agenda.
Vote 2020
Estos son algunos consejos para hacer cumplir eficazmente su voto y participar en las elecciones de su comunidad este año.
Editor’s Letter
Fight the Power
The results of the 2020 election will have many long-term consequences. There isn’t an issue that won’t be greatly affected, including HIV.
POZ Q+A
Boys From Brazil
Young adult author Lucas Rocha weaves a universal tale of HIV, romance, friendship and fun!
POZ Planet
Meth and HIV Among Latino MSM
Virtual discussions in Texas and Los Angeles shed light on “the dark side of the rainbow.”
Educate, Test and Navigate
A program to reduce HIV risk among Black and Latino youth
An HIV Plan for America
Details of the federal initiative to end the epidemic
Watch 2020/40 HIV Stories
Meet Latino activist Pedro Zamora and many others.
Everyday — October/November 2020
These dates represent milestones in the HIV epidemic.
Voices
For the Kids
Charles Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, urges us to learn from HIV.
From the Court
AIDS United explains the importance of three Supreme Court decisions, which the group views as two wins and a loss.
Spotlight
Vote 2020
HIV/AIDS and human rights groups have taken to social media to remind us of the various ways we can cast our ballots safely.
Basics
Dealing With Depression
Feeling sad or blue is common, but persistent depression can be treated.
Ask POZ
Ask POZ – October/November 2020
Ask POZ is an ongoing section on POZ.com dedicated to answering general wellness questions.
Care And Treatment
Rukobia OK’d for Resistant HIV
The novel attachment inhibitor led to viral suppression in 60% of people with extensive prior treatment.
Biktarvy Is Safe for Seniors
Pooled results from recent studies found a high rate of full viral suppression and no major safety concerns.
Dovato Approved as Switch Regimen
The single-tablet regimen is now approved for previously treated people with an undetectable viral load.
San Francisco’s Speedy Treatment Initiation
The city launched a program to start people on treatment within six days of diagnosis in 2015.
Adherence to HIV Meds in U.S. Is Poor
A recent analysis suggested that only one in four people on antiretroviral treatment take 95% or more of their doses.
Research Notes
Prevention: mRNA HIV Vaccine
New mRNA vaccine approach protects monkeys from HIV-like virus.
Treatment: Weight Gain
More studies link dolutegravir and other drugs to weight gain among people with HIV.
Cure: Gene Therapy
An experimental approach to protect HIV-fighting T cells has been cleared for its first human trial.
Concerns: COVID Consequences
Disruptions in prevention and treatment services due to the pandemic could cause a substantial increase in deaths in poorer nations.
Hereos
Translatina Proud
Cristina Herrera provides support for the Latinx transgender community.
Digital Edition
POZ October/November 2020
Read the digital edition!
